The main mechanism of action is that (BRAFi + MEKi) promotes the cleavage of GSDME while inducing pyroptosis and release of DAMPs to activate the activity of immune cells in the TME to cause anti‐tumour immunity. Here, GSDME is linked to neoplasm.